Astria Therapeutics Inc
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 59
- Market Cap
- -
- Website
- http://www.astriatx.com
- Introduction
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.
A Study of Navenibart in Participants With Hereditary Angioedema
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Astria Therapeutics, Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT06842823
- Locations
- 🇺🇸
Site 8, Centennial, Colorado, United States
🇺🇸Site 7, Cincinnati, Ohio, United States
🇺🇸Site 2, Scottsdale, Arizona, United States
A Study of STAR-0310 in Healthy Adult Participants
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Astria Therapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06782477
- Locations
- 🇺🇸
Austin Clinical Research Unit - Early Clinical Development, Austin, Texas, United States
A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
- First Posted Date
- 2023-08-23
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Astria Therapeutics, Inc.
- Target Recruit Count
- 56
- Registration Number
- NCT06007677
- Locations
- 🇺🇸
Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇧🇬Diagnostic Consultative Center Convex Ltd., Sofia, Bulgaria
🇨🇿Institute of Clinical Immunology/Allergology, Faculty Hospital, Hradec Kralove, Hradec Králové, Czechia
A Study of STAR-0215 in Participants With Hereditary Angioedema
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Astria Therapeutics, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT05695248
- Locations
- 🇺🇸
Acuro Research, Inc., Little Rock, Arkansas, United States
🇺🇸Allervie Clinical Research, Birmingham, Alabama, United States
🇺🇸Medical Research of Arizona a Division of Allergy, Asthma & Immunology Associates, LTD., Scottsdale, Arizona, United States
A Study of STAR-0215 in Healthy Adult Participants
- Conditions
- Hereditary Angioedema
- Interventions
- Drug: STAR-0215 (IV)Drug: STAR-0215 (SC)Drug: Placebo (IV)Drug: Placebo (SC)
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Astria Therapeutics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT05477160
- Locations
- 🇺🇸
Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States